ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,949.91
      1.83%
      US Tech 100
      20,645.60
      2.19%
      Dow Jones
      43,221.55
      1.65%
      Brent Oil
      81.705
      2.52%
      Bitcoin
      99,595.90
      3.20%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Germany
      5. TG

      6. Bristol Myers Squibb (BRM) Quote

      Bristol Myers Squibb

      Bristol Myers Squibb (BRM)

      Biorem Inc
      54.39
      0.29
      (0.54%)
      Closed January 15 4:00PM
      Realtime Data

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      54.39
      Bid
      54.09
      Ask
      54.47
      Volume
      4,285
      53.69 Day's Range 54.80
      36.315 52 Week Range 58.32
      Market Cap
      110.313B
      Previous Close
      54.10
      Open
      53.97
      Last Trade
      50
      @
      54.39
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      7,873
      Shares Outstanding
      2,028,176,674
      Dividend Yield
      4.69%
      PE Ratio
      14.13
      Earnings Per Share (EPS)
      3.96
      Revenue
      45.01B
      Net Profit
      8.03B

      About Bristol Myers Squibb

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.bms.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Bristol Myers Squibb is listed in the Pharmaceutical Preparations sector of the Tradegate (DE) with ticker BRM. The last closing price for Bristol Myers Squibb was 54.10 €. Over the last year, Bristol Myers Squibb shares have traded in a share price range of 36.315 € to 58.32 €.

      Bristol Myers Squibb currently has 2,028,176,674 shares outstanding. The market capitalization of Bristol Myers Squibb is 109.72 € billion. Bristol Myers Squibb has a price to earnings ratio (PE ratio) of 14.13.

      Ask ADVFN Intelligence (AI)

      BRM Latest News

      More News

      FeaturedZefiro Methane Corp. Subsidiary Awarded Slate of Government of Ohio-Funded Environmental Remediation Projects

      10 hours ago

      FeaturedMawson Finland Begins 2025 Drill Program, Mobilizing Multiple Drill Rigs at Rajapalot

      10 hours ago

      TOP NEWS: Bristol-Myers beats on revenue but swings to quarterly loss

      Bristol-Myers Squibb Co on Thursday reported a swing to a first-quarter loss on charges related to its acquisition of ...

      April 25 2024
      Alliance News

      Bristol-Myers inks USD380 million supply agreement with Cellares

      Bristol-Myers Squibb on Monday said it has signed an agreement to expedite the manufacturing of its CAR-T cell therap ...

      April 22 2024
      Alliance News

      IN BRIEF: BMS adds to neuroscience portfolio with Karuna acquisition

      ibb Co - New York-based pharmaceutical company - Completes acquisition of Karuna Therapeutics Inc, a Massachusetts-bas ...

      March 18 2024
      Alliance News

      TOP NEWS: Bristol-Myers quarterly revenue up as new products shine

      Bristol-Myers Squibb Co on Friday reported stronger fourth-quarter revenue, with sales from new drug launches increas ...

      February 02 2024
      Alliance News

      Bristol-Myers gets EMA validation for lung-cancer drug, repotrectinib

      Bristol-Myers Squibb Co on Tuesday announced that the European Medicines Agency had validated an application for a lu ...

      January 02 2024
      Alliance News

      TOP NEWS: Bristol-Myers makes second holiday acquisition with RayzeBio

      Bristol-Myers Squibb Co on Tuesday announced its second large acquisition in four days, saying it has agreed to buy N ...

      December 26 2023
      Alliance News

      TOP NEWS: Bristol-Myers swoops for schizophrenia drugmaker Karuna

      Bristol-Myers Squibb Co on Friday agreed to buy biopharmaceutical company Karuna Therapeutics Inc for USD14.0 billion ...

      December 22 2023
      Alliance News

      Leading pharmaceutical firms highlight positive trial data on lymphoma

      A number of leading pharmaceutical companies on Monday reported positive trial results on the treatment of lymphoma, ...

      December 11 2023
      Alliance News
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.7-1.270648030555.0955.5953.69433554.42895446DE
      4-0.35-0.63938618925854.7455.9953.2784354.83747875DE
      125.5111.272504091748.8858.3247.5787353.95383574DE
      2616.99545.447252306537.39558.3236.7834648.34907453DE
      528.5418.625954198545.8558.3236.3151036144.64801393DE
      156-2.16-3.8196286472156.5580.536.315503548.56891355DE
      260-5.8-9.6361521847560.1980.536.315451750.14547972DE

      BRM - Frequently Asked Questions (FAQ)

      What is the current Bristol Myers Squibb share price?
      The current share price of Bristol Myers Squibb is 54.39 €
      How many Bristol Myers Squibb shares are in issue?
      Bristol Myers Squibb has 2,028,176,674 shares in issue
      What is the market cap of Bristol Myers Squibb?
      The market capitalisation of Bristol Myers Squibb is EUR 109.72B
      What is the 1 year trading range for Bristol Myers Squibb share price?
      Bristol Myers Squibb has traded in the range of 36.315 € to 58.32 € during the past year
      What is the PE ratio of Bristol Myers Squibb?
      The price to earnings ratio of Bristol Myers Squibb is 14.13
      What is the cash to sales ratio of Bristol Myers Squibb?
      The cash to sales ratio of Bristol Myers Squibb is 2.52
      What is the reporting currency for Bristol Myers Squibb?
      Bristol Myers Squibb reports financial results in USD
      What is the latest annual turnover for Bristol Myers Squibb?
      The latest annual turnover of Bristol Myers Squibb is USD 45.01B
      What is the latest annual profit for Bristol Myers Squibb?
      The latest annual profit of Bristol Myers Squibb is USD 8.03B
      What is the registered address of Bristol Myers Squibb?
      The registered address for Bristol Myers Squibb is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
      What is the Bristol Myers Squibb website address?
      The website address for Bristol Myers Squibb is www.bms.com
      Which industry sector does Bristol Myers Squibb operate in?
      Bristol Myers Squibb operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      E3O1Nexoptic Technology Corp
      0.0245 €
      (58.06%)
      		43.88k
      QNTQuantum Corp
      32.20 €
      (47.71%)
      		20.27k
      CR6AWolfspeed Inc
      6.51 €
      (39.58%)
      		222.49k
      M000Vertical Aerospace Ltd
      10.30 €
      (32.05%)
      		1.08k
      34Q0Quantum eMotion Inc
      0.76 €
      (29.91%)
      		1.35M
      D4GDataMetrex AI Ltd
      0.0036 €
      (-37.93%)
      		3k
      7KOCullinan Metals Corp
      0.0072 €
      (-35.71%)
      		216.5k
      QJ4Auric Minerals Corp
      0.81 €
      (-33.33%)
      		2.14M
      CNWCodon AG
      0.0075 €
      (-31.82%)
      		150
      LL3PanGenomic Health Inc
      0.0901 €
      (-29.39%)
      		84
      PF8European Lithium Limited
      0.0386 €
      (10.92%)
      		10.32M
      D7GNel ASA
      0.196 €
      (1.82%)
      		6.56M
      RQ0DWave Quantum Inc
      5.628 €
      (22.19%)
      		5.63M
      QJ4Auric Minerals Corp
      0.81 €
      (-33.33%)
      		2.14M
      4IPParkway Corporate Ltd
      0.006 €
      (-6.25%)
      		2.03M

      Discussion

      View Full Feed
      TrendTrade2016 TrendTrade2016 3 minutes ago
      PMAX NICE BOTTOM CHART
      PMAX
      lodas lodas 4 minutes ago
      Capital remained overstated as the housing bubble began to burst because accounting rules enabled institutions to mask exposures and losses. Mark-to-market accounting rules in 200718 required financial institutions to write down losses to certain assets. However, many of these assets were illiquid a
      COOP
      tm3141 tm3141 4 minutes ago
      what time is tomorrow's hearing for Scott Bessent ?
      FNMA
      BigBadWolf BigBadWolf 4 minutes ago
      All is progressing as today shows yet actually I’d prefer that shareholders not fund their next acquisition as we have absorbed plenty while funding the RTO…time for the company & management to deliver the goods. Step up fulfill their roles to earn those shares while we watch this business plan come
      RDAR
      asp42001 asp42001 5 minutes ago
      Helping-Hand Prepaid Card Money FusioN?

      USIO's multilingual experience, could be called upon to P&H In/Out $$$,

      "LA" Hoch & Co., S.A. & Austin, TX, EBPP&H... location, location, location.

      Dial-Up EXPRESS helping-hand smart-cards 4 LA ? State, local & gov
      USIO
      2times2 2times2 5 minutes ago
      https://ihwiki.advfn.com/index.php/Community_Guidelines?_gl=1*1g7ul8g*_gcl_au*MTkyMjQzNTYxLjE3Mjk5NzE2NjY.
      CRSM
      jaramill jaramill 6 minutes ago
      $HHSE-NEWS:..Hannover House (HHSE) Positioned for Huge Growth from New Products and Financing

      Press Release | 01/10/2025

      https://www.otcmarkets.com/stock/HHSE/news/Hannover-House-HHSE-Positioned-for-Huge-Growth-from-New-Products-and-Financing?id=464170 (Click on link
      HHSE
      MR, MR, 6 minutes ago
      MY FRIEND the 10 day avg. is 526k Period. Get a clue.
      MONI
      Viewmont Viewmont 6 minutes ago
      $TNXP Someone shorting or wanting the stock to go down to .10 by creating FUD / Chaos for shareholders to sell at a loss for his benefit, is not happy at all now! His plan ddin't work, but, backfired!

      Just live and let live!
      Good luck all!
      TNXP
      jaramill jaramill 6 minutes ago
      $HHSE-NEWS:..HUGE-Step-Forward for HHSE-Shareholders! E-TRADE has released "trading-choke" on our stock!

      Wednesday, January 8, 2025

      (Click on link below read HHSE Blog)

      https://hannoverhousemovies.blogspot.com/2025/01/huge-step-forward-for-hhse-sharehold
      HHSE
      jaramill jaramill 6 minutes ago
      $HHSE-NEWS:..Promotional-Partnership.with 'X'-Platform Delivers-Huge-Initial-Response from U.S.-Consumers

      News Provided By

      Hannover House / MyFlix
      January 02, 2025, 18:43 GMT

      (Click on link below for EIN Presswire Article)

      https://w
      HHSE
      surfkast surfkast 8 minutes ago
      Why did you have to burst the idiot pumpers bubble? LOL
      FORW
      TrendTrade2016 TrendTrade2016 8 minutes ago
      it sure is
      PMAX
      tat4tat tat4tat 9 minutes ago
      The quarter ended on Sept 30 2024. How much time do they need. Is not 3 1/2 months a bit much. They said they were DONE and waiting for green light from legal. Did they lie? Cant wait to dump my position.
      CEOS
      ninedoors ninedoors 9 minutes ago
      The gist I get from reading Parrot and Zandi's impicit guarantee argument is that it's less of a counter-argument and more of a concern and acknowledgement that Trump's already going ahead with the privatization as they please.

      They also acknowledge that "given their much-improved ca
      FNMA
      igotthemojo igotthemojo 9 minutes ago
      That 4 year contract just expired a couple of months ago…so no, it’s not “too long ago”…

      If you don’t care one way or the other, why post at all?…
      KBLB
      Real McCoy Real McCoy 9 minutes ago
      It’s debunked fully because a Letter of Intent comes before the actual deal. You’ve seen the actual deal.
      varjim varjim 9 minutes ago
      https://www.otcmarkets.com/stock/ARRKF/news/Arras-Minerals-Drills-261-Metres--064-CuEq-In-First-Holes-at-Berezski-Central-Target---Elemes-Project-Kazakhstan?id=464760
      ARRKF
      NoMoDo NoMoDo 10 minutes ago
      You must be new here. Been happening for a few days. Question is not why, but when will it stop. I would assume it will be very soon. And news should be out today. I would be surprised if it doesn't hit before open tomorrow. Very surprised. Kinda backs me into a corner, but that is the truth.
      HMBL
      RichieBoy RichieBoy 10 minutes ago
      1jas YES AFFU is under NDA and definitely keeping a low profile. Binding means they have signed something... Here's the skinny, since they haven't CLOSED the acquisition, it's actually in there best interests to be in an NDA situation. I haven't got time to look it up , but think you'll find Quiet P
      AFFU

      Your Recent History

      TG
      BRM
      Bristol Myers Squibb
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads